Simbolo | YTM % | Volume | Prezzo % | Cedola % | Data di maturazione | Importo in eccesso | Valore nominale | Importo min. denominazione | Emittente |
---|---|---|---|---|---|---|---|---|---|
AA5QDALLERGAN FNDG 15/25 | 13,12% | 0 | 99,90% | 3,80% | 2025-03-15 | 130,22 M USD | 1.000,00 USD | 2.000,00 USD | Allergan Funding SCS |
8,33% | 1,77 M | 99,94% | 3,80% | 2025-03-15 | 2,89 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
AACT4218883Allergan Funding SCS 4.75% 15-MAR-2045 | 8,14% | 50 K | 74,10% | 4,75% | 2045-03-15 | 53,51 M USD | 1.000,00 USD | 2.000,00 USD | Allergan Funding SCS |
AACT4176286Allergan Funding SCS 4.85% 15-JUN-2044 | 7,69% | 15 K | 77,85% | 4,85% | 2044-06-15 | 65,23 M USD | 1.000,00 USD | 2.000,00 USD | Allergan Funding SCS |
AACT3910526Actavis, Inc. 4.625% 01-OCT-2042 | 7,23% | 134 K | 79,81% | 4,63% | 2042-10-01 | 67,49 M USD | 1.000,00 USD | 2.000,00 USD | Actavis, Inc. |
AACT4218882Allergan Funding SCS 4.55% 15-MAR-2035 | 6,31% | 750 K | 89,19% | 4,55% | 2035-03-15 | 107,65 M USD | 1.000,00 USD | 2.000,00 USD | Allergan Funding SCS |
5,83% | 12,91 M | 83,97% | 4,25% | 2049-11-21 | 5,75 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
5,74% | 26 K | 90,47% | 3,20% | 2029-11-21 | 62,52 M USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
5,72% | 0 | 87,85% | 4,45% | 2046-05-14 | 2 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
5,64% | 14,02 M | 89,03% | 4,40% | 2042-11-06 | 2,6 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
5,63% | 0 | 91,23% | 4,70% | 2045-05-14 | 2,7 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
5,61% | 2,4 M | 92,49% | 4,88% | 2048-11-14 | 1,75 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
5,59% | 36 K | 91,45% | 4,63% | 2042-10-01 | 389,22 M USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
5,57% | 684 K | 93,32% | 4,85% | 2044-06-15 | 1,01 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
5,53% | 6,83 M | 99,65% | 5,50% | 2064-03-15 | 1,5 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
5,52% | 9,75 M | 88,10% | 4,05% | 2039-11-21 | 4 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
5,46% | 30,08 M | 99,35% | 5,40% | 2054-03-15 | 3 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
5,39% | 950 K | 93,80% | 4,75% | 2045-03-15 | 827,09 M USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
5,39% | 16,24 M | 102,43% | 5,60% | 2055-03-15 | 750 M USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
5,35% | 1,44 M | 99,96% | 5,35% | 2044-03-15 | 750 M USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
5,16% | 0 | 93,87% | 4,30% | 2036-05-14 | 1 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
5,13% | 0 | 99,73% | 3,60% | 2025-05-14 | 3,75 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
5,06% | 2,51 M | 96,62% | 4,55% | 2035-03-15 | 1,68 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
5,04% | 0 | 96,39% | 4,50% | 2035-05-14 | 2,5 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
4,96% | 37,44 M | 101,61% | 5,20% | 2035-03-15 | 1 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
4,91% | 14,56 M | 100,87% | 5,05% | 2034-03-15 | 3 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
4,68% | 15,05 M | 94,29% | 3,20% | 2029-11-21 | 5,44 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
4,61% | 16 M | 101,58% | 4,95% | 2031-03-15 | 2 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
4,58% | 1,49 M | 101,21% | 4,88% | 2030-03-15 | 1 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
4,46% | 4,05 M | 101,17% | 4,80% | 2029-03-15 | 2,5 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
4,39% | 2,03 M | 99,56% | 4,25% | 2028-11-14 | 1,75 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
4,38% | 16,32 M | 100,73% | 4,65% | 2028-03-15 | 1,25 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
4,37% | 1,51 M | 97,75% | 2,95% | 2026-11-21 | 3,99 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
4,33% | 0 | 98,74% | 3,20% | 2026-05-14 | 2 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
4,29% | 8,32 M | 100,94% | 4,80% | 2027-03-15 | 2,25 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
XXS162262122ALLERGAN FNDG 17/29 | 4,08% | 0 | 92,95% | 2,13% | 2029-06-01 | 36,46 M EUR | 1.000,00 EUR | 100.000,00 EUR | Allergan Funding SCS |
4,06% | 0 | 95,40% | 2,63% | 2028-11-15 | 72,11 M EUR | 1.000,00 EUR | 100.000,00 EUR | Allergan Funding SCS | |
3,86% | 0 | 96,53% | 2,95% | 2026-11-21 | 9,24 M USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
3,30% | 0 | 88,75% | 1,25% | 2031-11-18 | 650 M EUR | 1.000,00 EUR | 100.000,00 EUR | AbbVie, Inc. | |
3,01% | 0 | 102,15% | 3,80% | 2025-03-15 | 1,27 M USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
3,00% | 0 | 96,72% | 2,13% | 2029-06-01 | 506,09 M EUR | 1.000,00 EUR | 100.000,00 EUR | AbbVie, Inc. | |
2,90% | 0 | 121,31% | 4,25% | 2049-11-21 | 4,95 M USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
2,89% | 0 | 99,11% | 2,63% | 2028-11-15 | 427,79 M EUR | 1.000,00 EUR | 100.000,00 EUR | AbbVie, Inc. | |
2,88% | 0 | 126,76% | 4,75% | 2045-03-15 | 5 K USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
2,83% | 0 | 128,71% | 4,85% | 2044-06-15 | 100 K USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
2,81% | 0 | 97,70% | 2,13% | 2028-11-17 | 750 M EUR | 1.000,00 EUR | 100.000,00 EUR | AbbVie, Inc. | |
2,74% | 0 | 95,02% | 0,75% | 2027-11-18 | 750 M EUR | 1.000,00 EUR | 100.000,00 EUR | AbbVie, Inc. | |
2,35% | 0 | 123,74% | 4,55% | 2035-03-15 | 1 K USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
— | — | — | 4,40% | 2042-11-06 | 1,1 M USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
— | — | — | 3,80% | 2025-03-15 | — | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. |